[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351703-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351703-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","optimizing-primary-human-salivary-stemprogenitor-cells-for-tissue-engineering-applications","Optimizing Primary Human Salivary Stem/Progenitor Cells for Tissue Engineering Applications","","This work aimed to establish a translationally viable, xeno-free, serum-free platform and protocol for isolating and expanding human salivary stem/progenitor cells to support regulatory qualification and future FDA-approved first-in-human autologous regenerative therapy for hyposalivation. Primary cells were isolated from consented non-cancerous parotid specimens, expanded under animal-component-free conditions, and CD44+ cells were enriched by magnetic sorting. Purity was assessed by cytokeratin markers, anti-CD133 and anti-fibroblast staining, phenotype validation via flow cytometry and immunocytochemistry, and senescence evaluation with SA-β-gal across P1–P6. CD44 expression stayed >95%, contaminants remained negligible, and minor donor-to-donor senescence increases (5–16%) supported retained proliferative potential and GMP compatibility.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/optimizing-primary-human-salivary-stemprogenitor-cells-for-tissue-engineering-applications/351703/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/optimizing-primary-human-salivary-stemprogenitor-cells-for-tissue-engineering-applications/351703.png","ImageObject",300,407,{"name":42,"@type":43},"Stanley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What platform and protocol did the study develop for salivary stem/progenitor cells?","Question",{"text":63,"@type":64},"A translationally viable xeno-free, serum-free platform and protocol for isolating and expanding human salivary stem/progenitor cells suitable for regulatory qualification and future autologous regenerative therapy trials.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were CD44+ salivary stem/progenitor cells isolated and enriched?",{"text":68,"@type":64},"After primary isolation from non-cancerous parotid tissue, cells were expanded under animal-component-free conditions and then CD44+ cells were enriched using magnetic cell sorting.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supported cell purity and controlled senescence across passages?",{"text":72,"@type":64},"Epithelial purity was assessed using cytokeratin markers and antibody-based checks showing negligible CD133 and fibroblast marker detection, with phenotype validation by flow cytometry and immunocytochemistry. Senescence was measured using SA-β-gal across P1–P6, showing only a minor, passagedependent increase (5–16%) in senescent cells while retaining proliferative potential.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351703,1790389470,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","bioRxiv preprint doi: [https://doi.org/10.64898/2026.05.12.724408](https://doi.org/10.64898/2026.05.12.724408); this version posted May 13, 2026. The copyright holder has placed this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, reuse, remix, or adapt this material for any purpose without crediting the original authors.  \nOptimizing Primary Human Salivary Stem/Progenitor Cells for Tissue Engineering Applications  \nThaise. C. Geremias1 , Fabio H. B. da Costa 1 ,2 Nadia G. Mohyuddin3 , Isabelle M. Lombaert4 , Mary C. Farach-Carson 1,2,5 , Danielle Wu 1,5 .  \n1 Diagnostic and Biomedical Sciences, School of Dentistry, The University of Texas Health Science Center at Houston, Houston, Texas  \n2 Department of Biosciences, Rice University, Houston, Texas  \n3 Academic Institute Department of Otolaryngology Houston Methodist Hospital, Houston Methodist, Weill Cornell Medical College  \n4 Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Harbor  \n5 Bioengineering, Rice University, Texas  \nTG: Conception and design, collection and/or assembly of data, analysis and interpretation,  \nmanuscript writing, final approval of manuscript.  \nFBC: Conception and design, collection and/or assembly of data, final approval of manuscript NGM: Collection and/or assembly of data, provision of study material or patient, collection and/or assembly of data, final approval of manuscript  \nIML: Conception and design, financial support, administrative support, final approval of manuscript MCFC: Conception and design, financial support, administrative support, provision of study material or patient, collection and/or assembly of data, data analysis and interpretation, manuscript writing, final approval of manuscript.  \nDW: Conception and design, administrative support, provision of study material or patients,  \ncollection and/or assembly of data, data analysis and interpretation, manuscript writing, final  \napproval of manuscript.  \nAll authors have read and agreed to the published version of the manuscript.  \nFunding agency:  \nThis work is supported by NIH/NIDCR 1R01DE032364 (to M.C. F.C. and I. M. L. ) and UT STARS AWARDS to M.C. F.C.  \nKey words: Stem/progenitor cells; salivary glands; regeneration; CD44 antigen; xerostomia  \nbioRxiv preprint doi: [https://doi.org/10.64898/2026.05.12.724408](https://doi.org/10.64898/2026.05.12.724408); this version posted May 13, 2026. The copyright holder has placed this preprint (which was not certified by peer review) in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, reuse, remix, or adapt this material for any purpose without crediting the original authors.  \nAbstract: This work aimed to establish a translationally viable, xeno-free, serum-free platform and protocol for the isolation and expansion of human salivary stem/progenitor cells (hS/PCs) suitable for regulatory qualification and future FDA-approved first-in-human autologous regenerative therapy trials for the treatment of hyposalivation disorders. Parotid gland specimens from non-cancerous regions/tissues were collected from consented surgical patients. Primary hS/PCs were isolated from tissue specimens, cultured in animal-component-free conditions, expanded to produce millions of cells, then enriched for CD44+ stem/progenitor cells by magnetic cell sorting. Normal epithelial purity was assessed using cytokeratins 5/14 . Anti-CD133/PROM1 (cancer marker) and antifibroblast (clone TE-7) antibodies were used to demonstrate a lack of contaminating cells. Phenotype validation was performed by flow cytometry and immunocytochemistry on both CD44+ sorted and unsorted populations . Senescence-associated beta-galactosidase (SA-β-gal) assays were performed across serial passages (P1–P6) . Pluripotency was demonstrated by culture under conditions supporting lineage-specific differentiation. Primary hS/PCs demonstr","cbCaic4jXI1x5mGV","https://ap.wps.com/l/cbCaic4jXI1x5mGV","pdf",6520199,"English","# Abstract\n# Introduction","[{\"question\":\"What platform and protocol did the study develop for salivary stem/progenitor cells?\",\"answer\":\"A translationally viable xeno-free, serum-free platform and protocol for isolating and expanding human salivary stem/progenitor cells suitable for regulatory qualification and future autologous regenerative therapy trials.\"},{\"question\":\"How were CD44+ salivary stem/progenitor cells isolated and enriched?\",\"answer\":\"After primary isolation from non-cancerous parotid tissue, cells were expanded under animal-component-free conditions and then CD44+ cells were enriched using magnetic cell sorting.\"},{\"question\":\"What evidence supported cell purity and controlled senescence across passages?\",\"answer\":\"Epithelial purity was assessed using cytokeratin markers and antibody-based checks showing negligible CD133 and fibroblast marker detection, with phenotype validation by flow cytometry and immunocytochemistry. Senescence was measured using SA-β-gal across P1–P6, showing only a minor, passagedependent increase (5–16%) in senescent cells while retaining proliferative potential.\"}]","Optimizing Primary Human Salivary Stem/Progenitor Cells for Tissue Engineering Applications | PDF",1790095427,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49422f44dfc69f6d4acdb451c7077d54.webp",983,1272,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/688a4291ae74aa59e912ff2a2d59fd4a.webp",982,1270,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1edd24876b50c0c0674ebd2c73db135.webp",981,1269,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/025f6e2e8f10cac8b2874508fadc0810.webp",980,1268]